Terms: = Thyroid cancer AND NBN, AT-V2, 4683, ENSG00000104320, ATV, FLJ10155, NBS, AT-V1, MGC87362, NBS1 AND Diagnosis
4 results:
1. Comparisons of Non-Oral Immune-Related Adverse Events Among Patients With cancer With Different Oral Toxicity Profiles.
Xu Y; Wen N; Haddad RI; Sonis ST; Villa A
Oncologist; 2024 Mar; 29(3):e382-e391. PubMed ID: 37874927
[TBL] [Abstract] [Full Text] [Related]
2. Outcomes and prognostic factors in thyroid cancer patients with cranial metastases: A retrospective cohort study of 4,683 patients.
Hong YW; Lin JD; Yu MC; Hsu CC; Lin YS
Int J Surg; 2018 Jul; 55():182-187. PubMed ID: 29883619
[TBL] [Abstract] [Full Text] [Related]
3. [Echo Doppler in the characterization of thyroid nodular disease].
Argalia G; D'Ambrosio F; Lucarelli F; Mignosi U; Giuseppetti GM; Passarini G; Russo M; Morosini PP; Taccaliti A; Arnaldi G
Radiol Med; 1995 May; 89(5):651-7. PubMed ID: 7617906
[TBL] [Abstract] [Full Text] [Related]
4. The diagnostic and therapeutic utility of radioiodinated metaiodobenzylguanidine (MIBG). 5 years of experience.
Troncone L; Rufini V; Montemaggi P; Danza FM; Lasorella A; Mastrangelo R
Eur J Nucl Med; 1990; 16(4-6):325-35. PubMed ID: 2351179
[TBL] [Abstract] [Full Text] [Related]
